In 2024, Eli Lilly and Co conducted an environmental assessment and disclosed corporate waste management data in accordance with recognized sustainability reporting standards.The company provided a breakdown of its waste by type (hazardous vs non-hazardous) and treatment method (recovery vs disposal), enabling greater transparency into its waste handling and environmental practices.
| Metric (tonnes) | 2024 | 2023 | 2022 | 2021-2019 |
|---|---|---|---|---|
Total Waste Generated | 125,000a | 116,000a | 121,000a | |
Total Waste Recovered | 112,000a | 103,000a | 109,000a | |
Total Hazardous Waste Generated | 27,000a | 19,000a | 22,000a | |
Non-Hazardous Waste Disposed | N/A | N/A | N/A |
You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"
Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.
In 2024, Eli Lilly and Co generated a total of 125,000metric tonnes of waste.a
Of this amount, 89.6% of Eli Lilly and Co's total waste generated was recovered through methods such as recycling, reuse, or composting, while 10.64% was disposed of through landfilling, incineration, or combustion.a
In 2024, Eli Lilly and Co reported a total waste generation of 125,000 metric tonnes, of which 89.6% was recovered through recycling, reuse, or composting.This high recovery rate suggests that Eli Lilly and Co has implemented strong circular economy practices and actively prioritizes sustainable waste management.a
Since 2020, Eli Lilly and Co's total waste generation decreased by 3.85%, yet rose by 7.76% in 2024, potentially indicating a temporary operational shift or inconsistency in waste management outcomes.a
Over the same period, Eli Lilly and Co's waste recovery rate declined by 2.93%, and then remained stable in 2024, possibly indicating that earlier setbacks have leveled off without signs of active improvement.a
Overall, Eli Lilly and Co’s waste generation and recovery data show a mixed and inconsistent trend. A deeper analysis of the company's activities, industry benchmarks, and operational changes is needed to assess its sustainability performance more precisely.
In 2024, Eli Lilly and Co generated a total of 125,000 metric tonnes of waste.a
Of this amount, 21.6% of Eli Lilly and Co's total waste generated of was classified as hazardous waste, characterized by properties such as toxicity, flammability, corrosiveness, or reactivity that may pose risks to human health, ecosystems, or the environment.78.4% was identified as non-hazardous waste, generally considered less harmful and subject to lighter regulatory controls.a
Since 2020, Eli Lilly and Co's total waste generation fell by 3.85%, but rose by 7.76% in 2024, potentially reflecting a temporary surge in activity or inconsistency in waste control strategies.a
Over the same period, the share of hazardous waste in Eli Lilly and Co's total output increased by 40.4%, including a further 31.87% rise in 2024, suggesting a troubling upward shift toward more environmentally harmful waste streams that could raise compliance costs and environmental risks.a
Overall, Eli Lilly and Co had previously reduced its waste generation, but recent increases in both volume and hazardousness suggest potential reversals or emerging operational risks that warrant further investigation.a